Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Fludarabine, Cyclophosphamide Plus TBI Conditioning Regimen for Double Units Cord Blood Transplantation in Severe Aplastic Anemia

NCT00881933 is registered in ClinicalTrials.gov with The Korean Society of Pediatric Hematology Oncology as lead sponsor.

NCT NCT00881933
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00881933 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Fludarabine, Cyclophosphamide Plus TBI Conditioning Regimen for Double Units Cord Blood Transplantation in Severe Aplastic Anemia
Lead sponsor
The Korean Society of Pediatric Hematology Oncology
Phase
Phase 1/2
Overall status
Unknown status
Start date
November 30, 2008
Completion date
September 30, 2012
Enrollment
5 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aplastic anemia